(And why most GTM teams misdiagnose the problem)
"Healthcare just moves slowly. There is too much bureaucracy, compliance, and too many stakeholders."
Healthcare does not have inherently long sales cycles. It has misaligned intelligence cycles. You are experiencing motion without momentum.
Teams anchor their motion where the product is used, but budget authority and risk sit elsewhere. Demos go well, but deals freeze.
Used in Layer 3 (Acute Care) but Approved in Layer 1 (Strategy & Capital).
Influence flows across systems, through committees, and via financial risk holders—not just direct reporting lines.
Key veto points remain invisible. IDNs, GPOs, and MSOs often control the outcome.
In healthcare, interest does not equal urgency. Buying only accelerates when a problem becomes an unavoidable operational stress.
Content downloads are mistaken for intent. The sales cycle hasn't lengthened—it hasn't actually started.
Healthcare organizations don't buy as individuals. They buy when multiple roles converge around a problem.
Missing the organizational density of intent causes teams to push too hard, or wait too long.
Healthcare buyers are strictly sequenced. Strategy decisions move annually; operational decisions move in response to immediate stress.
Engaging out of sequence forces conversations to restart repeatedly. Deals 'reset' without dying.
Use Intent.Health decision intelligence to map buyers, detect momentum, and engage accounts at the right time.
Get Intelligence →